B = bupivacaine HCl; LB = liposome bupivacaine.
*An 11-point numeric rating scale at rest (NRS-R) was used to assess pain intensity (PI) in all studies except Study 201, in which a 0- to 100 mm visual analog scale was used.
†Mean PI scores in the liposome bupivacaine group were lower beginning at 12 hours, and remained lower than bupivacaine HCl through 96 hours.
‡Mean PI scores in the liposome bupivacaine group were lower beginning at 60 hours, and remained lower than bupivacaine HCl through 96 hours.
§Mean PI scores in the liposome bupivacaine group were lower beginning at 2 hours, and remained lower than bupivacaine HCl through 96 hours.
‖Mean PI scores in the liposome bupivacaine group were higher than bupivacaine HCl at the 1, 2, and 4 hour assessments; they were lower than bupivacaine HCl at the 8 and 12 hour assessments; then, higher than bupivacaine HCl beginning at 24 hours and remained higher than bupivacaine HCl through 96 hours.